NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/23/2024
Back to search
Official data from USPTO
WUXI VACCINES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
WUXI VACCINES
ST13
US500000097735383Class
40, 42
Filing
97735383
Registration
7369079
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
04/23/2024
Trademark type
Word
Nice classes
40, 42
Filing date
12/29/2022
Registration date
04/23/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/23/2024
Last transaction
04/23/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Drawing code
4
Owner type
16
Owner location
Shanghai, CN
Examiner
WATTS-FITZGERALD, CAITLIN
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Shanghai Vaccines Co., Ltd.
Representatives
Eric Lamb FROST BROWN TODD LLP
Technical classification
Nice Classes
Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Custom assembling of materials for othersbeing custom manufacture of pharmaceuticalschemotherapy drugsantibiotic medicinesvaccines by pharmaceutical compounders; Custom manufacture of medical preparations in the nature of pharmaceuticals; Customized biomanufacturing of pharmaceuticals; Custom manufacture of vaccines for preventing or treating infectious diseasescancer and allergies or autoimmunity; Material processing being processing of medicinal plants and manufacturing of pharmaceuticals using biological organisms in the manufacturing processall in the medicinal field; Processing of drugsbeing biomanufacturing for others in the nature of custom manufacturing of pharmaceuticals; Processing of biomedical preparationsbiomanufacturing for others in the nature of manufacturing of pharmaceuticals and vaccines using biological organisms in the manufacturing process; Processing of vaccinesbeing custom manufacture of vaccines for preventing or treating infectious diseasescancer and allergies or autoimmunity
Class 42
Developing new products for others; Development of medicines; Scientific research and development; Pharmaceutical research; Research and development of new products; Consulting services in the field of development of new technology for others; Biochemical research and analysis; Biomedical research; Development of pharmaceutical preparations and pharmaceutical drugs; Research and development of pharmaceutical drugs; Custom design and development of chemical reagents for scientific or medical research use
Publications
History of USPTO decisions and trademark events.
20 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
04/23/2024
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
03/08/2024
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
03/04/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
03/04/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/04/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
03/04/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/04/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
12/04/2023
GNFR
FINAL REFUSAL E-MAILED
12/04/2023
CNFR
FINAL REFUSAL WRITTEN
12/04/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/30/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/30/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/30/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/27/2023
GNRT
NON-FINAL ACTION E-MAILED
09/27/2023
CNRT
NON-FINAL ACTION WRITTEN
09/27/2023
DOCK
ASSIGNED TO EXAMINER
09/26/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/24/2023
NWAP
NEW APPLICATION ENTERED
01/02/2023
Continuous trademark protection
Get notified about every new filing that threatens WUXI VACCINES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.